Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria (Q35836848)

10 August 2017

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria (English)

1 reference

10 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1324640

13 September 2022

2

D. M. Citron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1324640

13 September 2022

Ellie J. C. Goldstein

series ordinal

1

object named as

E. J. Goldstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1324640

13 September 2022

language of work or name

English

0 references

publication date

1 May 1992

1 reference

PMC publication ID

188857

full work available at URL

10 August 2017

https://europepmc.org/articles/PMC188857

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1324640

https://europepmc.org/articles/PMC188857?pdf=render

13 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1324640

Antimicrobial Agents and Chemotherapy

13 September 2022

published in

1 reference

10 August 2017

36

1 reference

10 August 2017

5

1 reference

10 August 2017

1158-1162

1 reference

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

Is ciprofloxacin active against clinically important anaerobes?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

In vitro activity of sparfloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188857

The in-vitro activity of PD127,391, a new quinolone

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1324640

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Central catheter infection: Single-versus triple-lumen catheters

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1324640

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.36.5.1158

1 reference

10 August 2017

1 reference

PMC publication ID

188857

10 August 2017

1 reference

PMC publication ID

188857